Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Polla Magnus"'
Publikováno v:
In Bioorganic & Medicinal Chemistry 1 April 2014 22(7):2261-2268
Autor:
Elena Reckzeh, Dennis Schade, Marc N. Hirt, Polla Magnus, Tessa Werner, Fabian Wesseler, Thomas Eschenhagen, Daniel Längle, Lauren Drowley, Niklas Schaumann, Alleyn T. Plowright
Publikováno v:
ChemMedChem. 14:810-822
Innovative therapeutic modalities for pharmacological intervention of transforming growth factor β (TGFβ)-dependent diseases are of great value. b-Annelated 1,4-dihydropyridines (DHPs) might be such a class, as they induce TGFβ receptor type II de
Autor:
Polla, Magnus O., Tottie, Louise, Nordén, Carita, Linschoten, Marcel, Müsil, Djordje, Trumpp-Kallmeyer, Susanne, Aukrust, Inger R., Ringom, Rune, Holm, Kjetil H., Neset, Siren M., Sandberg, Marcel, Thurmond, John, Yu, Peng, Hategan, Georgeta, Anderson, Herb
Publikováno v:
In Bioorganic & Medicinal Chemistry 1 March 2004 12(5):1151-1175
Autor:
C. Wern, Y. Örtengren, M. Strimfors, Ulf Eriksson, S. Nielsen, A.-C. Egnell, Ulf Bredberg, Joakim Bergman, T. Skjaeret, S. Pehrsson, Jonas Brånalt, K.-J. Hoffman, K. Abrahamsson, Ingemar Nilsson, Maria Ölwegård-Halvarsson, Polla Magnus, David Gustafsson, P. Andersson
Publikováno v:
MedChemComm. 7:272-281
A novel series of neutral thrombin inhibitors has been developed using a selection process based on docking experiments and property calculations and predictions. This work resulted in the identification of the highly potent thrombin inhibitor compou
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lisbeth Kristensson, Maria Sörhede Winzell, Sam D. Groombridge, Piotr Raubo, Andrea Ahnmark, William McCoull, Monika Sundqvist, Susanna Myhre, Polla Magnus, Ann-Christin Nyström, Linda Sundström, Mats Någård
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0189060 (2017)
PLoS ONE
PLoS ONE
The mechanism behind the glucose lowering effect occurring after specific activation of GPR120 is not completely understood. In this study, a potent and selective GPR120 agonist was developed and its pharmacological properties were compared with the
Autor:
Elise J. Needham, Maryam Clausen, Benjamin L. Parker, Alleyn T. Plowright, Henrik Andersson, Aurélie Bornot, Mei Ding, Gregory A. Quaife-Ryan, Polla Magnus, Richard J. Mills, Qing-Dong Wang, James E. Hudson, Enzo R. Porrello, Lauren Drowley, Holly K. Voges, David E. James, Ian P. Barrett, David A. Elliott
Publikováno v:
Cell Stem Cell. 24:895-907.e6
We have previously developed a high-throughput bioengineered human cardiac organoid (hCO) platform, which provides functional contractile tissue with biological properties similar to native heart tissue, including mature, cell-cycle-arrested cardiomy
Autor:
Polla Magnus, Lauren Drowley, Alleyn T. Plowright, Daniel Längle, Marc N. Hirt, Dennis Schade, Niklas Schaumann, Elena Reckzeh, Fabian Wesseler, Tessa Werner, Thomas Eschenhagen
Publikováno v:
ChemMedChem. 14:796-796
Autor:
Nilsson, Ingemar1 Ingemar.nilsson@astrazeneca.com, Polla, Magnus1 Magnus.polla@astrazeneca.com
Publikováno v:
Journal of Computer-Aided Molecular Design. Oct2012, Vol. 26 Issue 10, p1143-1157. 15p. 1 Color Photograph, 2 Diagrams, 3 Charts, 8 Graphs.